Table 5.
LUS findings at follow-up in relevant interstitial lung sequelae (RILS) groups categorized according to the Warrick score.
| Non-RILS group (n = 198) | RILS group (n = 154) | Total (N = 352) | *P-value | |
|---|---|---|---|---|
| LUS findings, n (%) | ||||
| B-lines in any area | 105 (53.0) | 152 (98.7) | 257 (73.0) | <0.001 |
| B-lines ≥ 3 areas | 36 (18.2) | 145 (94.2) | 181 (51.4) | <0.001 |
| Coalescent B-lines | 24 (12.1) | 28 (18.2) | 52 (14.8) | 0.322 |
| Thickened pleural line in any area | 71 (35.9) | 119 (77.3) | 190 (53.9) | <0.001 |
| Fragmented pleural line in any area | 0 (0) | 12 (7.8) | 12 (3.4) | 0.015 |
| Pleural effusion | 0 (0) | 3 (1.9) | 3 (0.9) | 0.722 |
| Consolidations | 3 (1.5) | 10 (6.5) | 13 (3.7) | 0.081 |
| LUS B-line score (0–12), median (IQR) | 1.0 (0.0–2.0) | 5.0 (4.0–9.0) | 3.0 (0.0–5.0) | <0.001 |
*
P-value comparisons between non-RILS and RILS groups.
RILS, relevant interstitial lung sequelae defined as by Warrick score ≥7.
IQR, interquartile range; RILS, relevant interstitial lung sequelae.